Analyst Ratings and Financial Health of Gilead Sciences, Inc. (NASDAQ:GILD)

"(GILD) Earns "Hold" Rating from Maxim Group" was first posted by TrueBlueTribune and is the property of of TrueBlueTribune. The stock has "Buy" rating by Oddo & Cie on Tuesday, August 16. Leerink Swann maintained the shares of GILD in report on Thursday, October 19 with "Market Perform" rating. After $2.51 actual earnings per share reported by Gilead Sciences, Inc. for the previous quarter, Wall Street now forecasts -17.53% negative EPS growth. Out of 20 total analysts who were surveyed, 1 rated it a Moderate Buy, 10 rated it hold, and 9 rated it a Strong Buy. Redburn Partners started coverage on Gilead Sciences in a research note on Wednesday, July 26th. The rating was upgraded by Societe Generale to "Buy" on Wednesday, May 18. Cowen and Company set a $120.00 price target on Gilead Sciences and gave the company a buy rating in a research report on Sunday, October 23rd. 73,333 shares were sold by MARTIN JOHN C, worth $4.78 million on Thursday, June 1.

The company's stock is now moving with a +ve distance from the 200 day SMA of approximately 7.13%, and has a solid year to date (YTD) performance of 7.62% which means that the stock is constantly adding to its value from the previous fiscal year end price. Clifford Swan Investment Counsel Llc sold 5,947 shares as Gilead Sciences Inc (GILD)'s stock declined 8.05%. The stock increased 2.53% or $0.11 on October 27, reaching $4.46. The firm has a market capitalization of $99.37 billion, a PE ratio of 8.26 and a beta of 1.14.

For the Current Quarter, the growth estimate for Gilead Sciences -32.2%, while for the Next Quarter the stock growth estimate is -15.7%.

The Stock had a 1.94 Consensus Analyst Recommendation 30 Days Ago, whereas 60 days ago and 90 days ago the analyst recommendations were 2 and 2.12 respectively. Gilead Sciences had a net margin of 42.22% and a return on equity of 57.15%.

Analysts are also projecting an Average Revenue Estimate for Gilead Sciences $5.79 Million in the Current Quarter.

Quarterly Earnings Growth on year-over-year basis stands at -9.6 percent.

EVP, CFO, Washington Robin L, sold 51,820 common shares of Gilead Sciences, Inc. S&Co has invested 0.06% in Gilead Sciences, Inc. (NASDAQ:GILD). Natixis has 739,347 shares. If you are viewing this story on another site, it was stolen and republished in violation of USA and worldwide trademark and copyright legislation.

Nikko Asset Management Americas Inc. raised its holdings in shares of Gilead Sciences, Inc.

The business also recently declared a quarterly dividend, which will be paid on Thursday, December 28th. (NASDAQ:GILD). Geode Cap Management Lc invested in 0.42% or 15.09 million shares. As per Thursday, December 1, the company rating was downgraded by Guggenheim.

After a recent scan, we can see that Gilead Sciences, Inc. The Accuvest Global Advisors holds 7,852 shares with $556,000 value, down from 16,138 last quarter. 07, 2017, the shares were put up for sale at an average price of $85, raking in a sum of $4,404,700. Following the transaction, the chief financial officer now directly owns 43,352 shares in the company, valued at approximately $3,684,920. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Another trade for 9,943 shares valued at $668,667 was made by Cogan John Francis on Tuesday, May 9. The stock was sold at an average price of $75.86, for a total value of $5,563,041.38. Amer Mgmt owns 41,000 shares. The disclosure for this sale can be found here. In the last ninety days, insiders sold 446,819 shares of company stock worth $36,338,919. The stock was sold at an average price of $81.97, for a total value of $286,895.00.

Several institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Parnassus Investments CA increased its position in shares of Gilead Sciences by 37.4% in the first quarter. Muhlenkamp & Co Inc bought 200,985 shares as the company's stock declined 8.05% while stock markets rallied.

According to Suncor Energy Inc.'s Insider ownership is at 0.04%. Jacobs Levy Equity Mngmt Inc holds 0.47% or 312,654 shares. FMR LLC grew its position in Gilead Sciences by 1.1% in the 2nd quarter. The stock decreased 1.04% or $0.81 on October 27, reaching $77.07.

Gilead Sciences, Inc is a research-based biopharmaceutical company that discovers, develops and commercializes medicines in areas of unmet medical need. The recent change has given its price a -4.55% deficit over SMA 50 and -10.66% deficit over its 52-week high.

Institutional ownership refers to the ownership stake in a company that is held by large financial organizations, pension funds or endowments. The Earnings Yield for Gilead Sciences, Inc. The Company's portfolio of products and pipeline of investigational drugs includes treatments for Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome (HIV/AIDS), liver diseases, cancer, inflammatory and respiratory diseases and cardiovascular conditions.

Like this



31 October 2017
Tiger Woods to return to golf
In recent weeks, Woods has posted practice videos, leading to speculation that his return was imminent. Woods underwent back surgery back in April, missing the Masters for a second year running.

31 October 2017
Roger Federer beats Juan Martin to win Base title
Other big names such as Andy Murray , Novak Djokovic , and Stan Wawrinka also will miss Paris. "Basel takes a lot out of me emotionally".

31 October 2017
Gas Prices Inch Up From Last week
He also said prices may rise and fall over the next few weeks as refineries continue maintenance work and inventories stay high. Moderate price increases in several parts of the region can be attributed to the steady decline in gas inventories.

30 October 2017
PS4 Owners Can Play Monster Hunter World as Aloy; Beta Date Confirmed
And the PS4 exclusive announcements didn't end here, as the company also revealed a beta for the game starting on December 9. The first of these offers a look at the three quest missions that will be included in the beta.

30 October 2017
North Korea flies balloons to Seoul with message 'Trump is mentally ill'
Trump will be in South Korea on November 7 and the United States has already dispatched three nuclear-powered aircraft carriers to the area.

30 October 2017
Cabaret law prohibiting unlicensed dancing moves toward repeal
On Tuesday, the bill will come before the City Council and Espinal says he has the 26 votes needed to pass it. If they have their way, you'll be able to dance if you want to, without leaving your favorite bars behind.

30 October 2017
Chelsea boss Antonio Conte: Roma game more important than Man Utd showdown
But [Eden] Hazard's ankle, Pedro's fractured's important for us to do our very best, always, and not have any regrets".

30 October 2017
We won't shut down Al-Jazeera, says Qatar emir
On the efforts to resolve the Gulf crisis, the emir pointed out that he is more than willing to sit down with his antagonists. Doha rejected all the demands, denouncing them as attempts to infringe Qatar's sovereignty. "We do not support terrorism".

30 October 2017
Bethenny Frankel Freaks Out As Beloved Dog Has Seizure For 45 Minutes
My poor daughter and I are watching my dog have a seizure for 45 minutes and the [vet] hospital's so far out. Unfortunately, Cookie experienced two more seizures during the evening on October 29.

30 October 2017
BREAKING Lindsey Stirling Badly Injured During DWTS Rehearsal! Is She Out?
Lindsay Stirling has been wowing " Dancing With The Stars " viewers since the first week of the season. Even if they are able to perform, Lindsey may not be 100 percent and it could also hurt her team.